Skip to content

Insider · CIK 0001644087

Joanne M. Donovan

officer

Files at EWTX (Edgewise Therapeutics, Inc.). First filing Jan 30, 2025, latest Aug 14, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $814k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

EWTX: Edgewise Therapeutics, Inc.

EWTXOct 9, 2026 · close 39.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
26Weak
EWTXsell 6
Edgewise Therapeutics, Inc.
$38k
2,862 shares
-10%+17% from low-63% from high
29Weak
EWTXsell 6
Edgewise Therapeutics, Inc.
$85k
5,187 shares
-19%+48% from low-54% from high
36Weak
EWTXsell 410b5-1
Edgewise Therapeutics, Inc.
$691k
25,000 shares
-60%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+5,781$0.00$028,223Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock
-2,862$13.39$38k25,361Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-5,781$0.00$017,344Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AGrant or award
Restricted Stock Unitsderivative
+28,125$0.00$028,125Aug 14, 2025
Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+168,750$0.00$0168,750Aug 14, 2025
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+10,417$0.00$026,775May 7, 2025
May 2, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock
-5,187$16.45$85k21,588May 7, 2025
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-10,417$0.00$00May 7, 2025
Jan 28, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+25,000$7.08$177k41,358Jan 30, 2025
Jan 28, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-25,000$27.63$691k16,358Jan 30, 2025
Jan 28, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$0.00$0175,000Jan 30, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joanne M. Donovan: insider trades and track record | InsiderTell